日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825

胶质母细胞瘤患者血管毒性的临床和遗传标志物:来自NRG Oncology RTOG-0825研究的启示

Strauss, Joshua D; Gilbert, Mark R; Mehta, Minesh; Li, Ang; Zhou, Renke; Bondy, Melissa L; Sulman, Erik P; Yuan, Ying; Liu, Yanhong; Vera, Elizabeth; Wendland, Merideth M; Stieber, Volker W; Puduvalli, Vinay K; Choi, Serah; Martinez, Nina L; Robins, H Ian; Hunter, Grant K; Lin, Chi-Fan; Guedes, Vivian A; Richard, Melissa A; Pugh, Stephanie L; Armstrong, Terri S; Scheurer, Michael E

Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825

独立验证的性别特异性列线图,用于预测新诊断胶质母细胞瘤患者的生存期:NRG Oncology RTOG 0525 和 0825

Patil, Nirav; Somasundaram, Eashwar; Waite, Kristin A; Lathia, Justin D; Machtay, Mitchell; Gilbert, Mark R; Connor, James R; Rubin, Joshua B; Berens, Michael E; Buerki, Robin A; Choi, Serah; Sloan, Andrew E; Penas-Prado, Marta; Ashby, Lynn S; Blumenthal, Deborah T; Werner-Wasik, Maria; Hunter, Grant K; Flickinger, John C; Wendland, Merideth M; Panet-Raymond, Valerie; Robins, H Ian; Pugh, Stephanie L; Mehta, Minesh P; Barnholtz-Sloan, Jill S

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

NRG/RTOG 1122:一项评估贝伐珠单抗联合或不联合trebananib治疗复发性胶质母细胞瘤或胶质肉瘤患者的II期双盲安慰剂对照研究

Lee, Eudocia Q; Zhang, Peixin; Wen, Patrick Y; Gerstner, Elizabeth R; Reardon, David A; Aldape, Kenneth D; deGroot, John F; Pan, Edward; Raizer, Jeffrey J; Kim, Lyndon J; Chmura, Steven J; Robins, H Ian; Connelly, Jennifer M; Battiste, James D; Villano, John L; Wagle, Naveed; Merrell, Ryan T; Wendland, Merideth M; Mehta, Minesh P

Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant

肾移植后亚临床急性排斥反应新型血液分子生物标志物的开发和临床有效性研究

Friedewald, John J; Kurian, Sunil M; Heilman, Raymond L; Whisenant, Thomas C; Poggio, Emilio D; Marsh, Christopher; Baliga, Prabhakar; Odim, Jonah; Brown, Merideth M; Ikle, David N; Armstrong, Brian D; Charette, Jane I; Brietigam, Susan S; Sustento-Reodica, Nedjema; Zhao, Lihui; Kandpal, Manoj; Salomon, Daniel R; Abecassis, Michael M

The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy

接受美金刚治疗以预防全脑放疗期间认知功能障碍的患者,其健康相关生活质量与认知功能之间的关联

Laack, Nadia N; Pugh, Stephanie L; Brown, Paul D; Fox, Sherry; Wefel, Jeffrey S; Meyers, Christina; Choucair, Ali; Khuntia, Deepak; Suh, John H; Roberge, David; Wendland, Merideth M; Bruner, Deborah

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913

一项随机 II 期研究评估依维莫司联合放化疗治疗新诊断的胶质母细胞瘤的疗效:NRG Oncology RTOG 0913 研究结果

Chinnaiyan, Prakash; Won, Minhee; Wen, Patrick Y; Rojiani, Amyn M; Werner-Wasik, Maria; Shih, Helen A; Ashby, Lynn S; Michael Yu, Hsiang-Hsuan; Stieber, Volker W; Malone, Shawn C; Fiveash, John B; Mohile, Nimish A; Ahluwalia, Manmeet S; Wendland, Merideth M; Stella, Philip J; Kee, Andrew Y; Mehta, Minesh P

Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database

胶质母细胞瘤患者放疗启动时间的短暂延迟——同步化疗的影响:来自NRG肿瘤/放射治疗肿瘤组数据库的二次分析

Blumenthal, Deborah T; Won, Minhee; Mehta, Minesh P; Gilbert, Mark R; Brown, Paul D; Bokstein, Felix; Brachman, David G; Werner-Wasik, Maria; Hunter, Grant K; Valeinis, Egils; Hopkins, Kirsten; Souhami, Luis; Howard, Steven P; Lieberman, Frank S; Shrieve, Dennis C; Wendland, Merideth M; Robinson, Cliff G; Zhang, Peixin; Corn, Benjamin W